ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 963,96
0,11%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. TG Therapeutics Inc (TGTX)

  7. TG Therapeutics Inc (TGTX) Actualités

TGTX

TG Therapeutics (TGTX)

TG Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TGTX
DateHeureSourceTitreSymboleSociété
01/05/202413h00GlobeNewswire Inc.TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial ResultsNASDAQ:TGTXTG Therapeutics Inc
30/04/202422h55GlobeNewswire Inc.TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business UpdateNASDAQ:TGTXTG Therapeutics Inc
18/04/202413h30GlobeNewswire Inc.TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual MeetingNASDAQ:TGTXTG Therapeutics Inc
18/04/202413h00GlobeNewswire Inc.TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple SclerosisNASDAQ:TGTXTG Therapeutics Inc
15/04/202413h30GlobeNewswire Inc.TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual MeetingNASDAQ:TGTXTG Therapeutics Inc
08/03/202413h30GlobeNewswire Inc.TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual MeetingNASDAQ:TGTXTG Therapeutics Inc
01/03/202413h30GlobeNewswire Inc.TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual ForumNASDAQ:TGTXTG Therapeutics Inc
29/02/202423h23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TGTXTG Therapeutics Inc
28/02/202413h24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TGTXTG Therapeutics Inc
28/02/202413h00GlobeNewswire Inc.TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial ResultsNASDAQ:TGTXTG Therapeutics Inc
27/02/202413h30GlobeNewswire Inc.TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy)NASDAQ:TGTXTG Therapeutics Inc
26/02/202413h00GlobeNewswire Inc.TG Therapeutics Announces European Launch of BRIUMVI® (ublituximab-xiiy)NASDAQ:TGTXTG Therapeutics Inc
23/02/202413h30GlobeNewswire Inc.TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2023 Financial Results and Business UpdateNASDAQ:TGTXTG Therapeutics Inc
20/02/202413h30GlobeNewswire Inc.TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual ForumNASDAQ:TGTXTG Therapeutics Inc
15/02/202403h53Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:TGTXTG Therapeutics Inc
14/02/202421h30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TGTXTG Therapeutics Inc
10/01/202413h00GlobeNewswire Inc.TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2023 Net Revenue and 2024 Anticipated MilestonesNASDAQ:TGTXTG Therapeutics Inc
09/01/202415h20AllPennyStocks.comBiotech Massively Bid Up Before Opening BellNASDAQ:TGTXTG Therapeutics Inc
09/01/202413h00GlobeNewswire Inc.TG Therapeutics Announces Global License Agreement with Precision BioSciences for the Development and Commercialization of Precision’s Allogeneic CD19 CAR T Cell Therapy Program for the Treatment of Autoimmune DiseasesNASDAQ:TGTXTG Therapeutics Inc
09/01/202400h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TGTXTG Therapeutics Inc
05/01/202417h02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TGTXTG Therapeutics Inc
05/01/202413h30GlobeNewswire Inc.TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TGTXTG Therapeutics Inc
27/11/202313h30GlobeNewswire Inc.TG Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:TGTXTG Therapeutics Inc
06/11/202323h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TGTXTG Therapeutics Inc
03/11/202312h30GlobeNewswire Inc.TG Therapeutics to Participate in the 5th Annual Guggenheim Inflammation, Neurology & Immunology (INI) ConferenceNASDAQ:TGTXTG Therapeutics Inc
01/11/202312h30GlobeNewswire Inc.TG Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:TGTXTG Therapeutics Inc
30/10/202312h30GlobeNewswire Inc.TG Therapeutics to Host Conference Call on Third Quarter 2023 Financial Results and Business UpdateNASDAQ:TGTXTG Therapeutics Inc
12/10/202317h00GlobeNewswire Inc.TG Therapeutics Announces Presentation of Data for BRIUMVI at the 2023 European Committee for Treatment and Research in Multiple Sclerosis Annual MeetingNASDAQ:TGTXTG Therapeutics Inc
02/10/202313h30GlobeNewswire Inc.TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2023 European Committee for Treatment and Research in Multiple Sclerosis Annual MeetingNASDAQ:TGTXTG Therapeutics Inc
22/09/202313h30GlobeNewswire Inc.TG Therapeutics to Participate in the 2023 Cantor Global Healthcare ConferenceNASDAQ:TGTXTG Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TGTX

Dernières Valeurs Consultées

EU
BEL20
Bel 20
EU
LR
Legrand
NASDAQ
GOOGL
Alphabet
NASDAQ
MSFT
Microsoft
NYSE
DIS
Walt Disney
SPI
SP500
S&P 500
NYSE
MCD
McDonalds
EU
ML
Michelin
EU
ACA
Credit Agricole
NYSE
MRK
Merck
EU
SGO
Cie de SaintGobain
FTSE
UKX
FTSE 100
EU
PX4
SBF 120
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés